Literature DB >> 17703909

Analgesic adherence measurement in cancer patients: comparison between electronic monitoring and diary.

Wendy H Oldenmenger1, Michael A Echteld, Rianne de Wit, Peter A E Sillevis Smitt, Dirk L Stronks, Gerrit Stoter, Carin C D van der Rijt.   

Abstract

Adherence to analgesics in cancer patients has scarcely been studied. In this study, the Medication Event Monitoring System (MEMS) and medication diaries were compared with respect to feasibility and adherence measurements. Forty-six outpatients with nociceptive pain caused by cancer were asked to use MEMS for their analgesics and to record their medication usage in a diary for four weeks. Seventy-nine percent of the patients used MEMS for the full four-week period; 70% did so for the diary. The majority of patients were satisfied with both MEMS and diary. Adherence data assessed by MEMS and diary were comparable. Patients used the amount of analgesics adequately (taking adherence: 87%) but took them irregularly (timing adherence: 53%). Subgroup analyses in patients using single and multiple analgesic regimens confirmed the comparable suitability of both methods. MEMS and a medication diary are equally useful for analgesic adherence measurement in cancer patients with pain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17703909     DOI: 10.1016/j.jpainsymman.2007.01.015

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  10 in total

1.  Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients.

Authors:  Christine M G Olthoff; Juliette G M M Hoevenaars; Bart W van den Borne; Carroll A B Webers; Jan S A G Schouten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-09-19       Impact factor: 3.117

2.  Adherence to Analgesics for Cancer Pain: A Comparative Study of African Americans and Whites Using an Electronic Monitoring Device.

Authors:  Salimah H Meghani; Aleda M L Thompson; Jesse Chittams; Deborah W Bruner; Barbara Riegel
Journal:  J Pain       Date:  2015-06-14       Impact factor: 5.820

3.  Patient Patterns and Perspectives on Using Opioid Regimens for Chronic Cancer Pain.

Authors:  Emily M Wright; Areej El-Jawahri; Jennifer S Temel; Alaina Carr; Steven A Safren; Elyse R Park; William F Pirl; Eduardo Bruera; Lara Traeger
Journal:  J Pain Symptom Manage       Date:  2019-03-01       Impact factor: 3.612

Review 4.  Access to opioid analgesics and pain relief for patients with cancer.

Authors:  Shalini Dalal; Eduardo Bruera
Journal:  Nat Rev Clin Oncol       Date:  2013-01-15       Impact factor: 66.675

Review 5.  A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence.

Authors:  Mohamed El Alili; Bernard Vrijens; Jenny Demonceau; Silvia M Evers; Mickael Hiligsmann
Journal:  Br J Clin Pharmacol       Date:  2016-05-02       Impact factor: 4.335

6.  INTEGRATING TECHNOLOGICAL ADVANCEMENTS IN BEHAVIORAL INTERVENTIONS TO PROMOTE HEALTH: UNPRECEDENTED OPORTUNITIES FOR BEHAVIOR ANALYSTS.

Authors:  Allison N Kurti; Jesse Dallery
Journal:  Rev Mex Anal Conducta       Date:  2014-09

7.  Adherence to Analgesics Among Outpatients Seriously Ill With Cancer.

Authors:  Stephen J Stapleton; Brenda W Dyal; Andrew D Boyd; Marie L Suarez; Miriam O Ezenwa; Yingwei Yao; Diana J Wilkie
Journal:  Cancer Nurs       Date:  2022-02-16       Impact factor: 2.760

8.  A New Frontier: Integrating Behavioral and Digital Technology to Promote Health Behavior.

Authors:  Jesse Dallery; Allison Kurti; Philip Erb
Journal:  Behav Anal       Date:  2014-08-23

9.  A pilot study to identify correlates of intentional versus unintentional nonadherence to analgesic treatment for cancer pain.

Authors:  Salimah H Meghani; Deborah Watkins Bruner
Journal:  Pain Manag Nurs       Date:  2011-05-06       Impact factor: 1.929

10.  The Challenge of Cancer Pain Assessment.

Authors:  Radhika Rani Gulati
Journal:  Ulster Med J       Date:  2021-02-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.